TGA issues product defect correction

Pharmacists are advised that Janssen is undertaking a product defect correction for one batch of Jurnista (hydromorphone hydrochloride) prolonged-release blister packs Janssen, following consultation with the TGA, is undertaking a product defect correction for one batch of Jurnista (hydromorphone hydrochloride) prolonged-release blister packs (8 mg, 14 tablets) due to potential damage to the tablets. A misalignment issue with